Pragma Bio Secures $10M From The Venture Collective, Merck Global Health Innovation Fund, Viking Global, and CJ Investments To Expand Its Proprietary Technology Platform To Discover Novel Medicines

Pragma Bio developed a first-of-its-kind-map of chemicals designed by nature, housed in
humans, and linked to immune-related health outcomes

Scroll to Top